AdipoPharma Belgique SRL
AdipoPharma Belgique reported total assets of 398,195 € at the end of the 2025 financial year (annual accounts filed with the NBB on 03 Aug 2026).
The score of AdipoPharma Belgique shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
The full file covers 2 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AdipoPharma Belgique's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
AdipoPharma Belgique's financial analysis
- Solvency0.4%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AdipoPharma Belgique
AdipoPharma Belgique's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1008.146.338
- VAT number
- BE1008146338
- Peppol
- Registered · 0208:1008146338 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Apr 2024
- Registered office
- 6041 Charleroi
- Latest accounts
- 2025 · filed on 03 Aug 2026
- Activity
- Manufacture of other pharmaceutical products (NACE 21209)
AdipoPharma Belgique (SRL) has been based in Charleroi since 2024, active in: manufacture of other pharmaceutical products. For 2025, it reports a net loss of 1,848 € and equity of 1,766 €; its revenue is not published. Its solvency stands at 0.4%, below the median of its sector (34.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to AdipoPharma Belgique
Companies in the same business, of comparable size and area, outside its group.
- L - Pharma Manufacture of pharmaceutical preparations Turnhout · balance sheet 10 €
- RTLC Manufacture of pharmaceutical preparations Brussels · balance sheet 107,167 €
- Oropharma Manufacture of pharmaceutical preparations Deinze · balance sheet 352,437 €
- DJB Medical Wholesale of pharmaceutical and medical goods Merchtem · balance sheet 406,739 €
- Laboratoires Sopreli Manufacture of pharmaceutical preparations Anderlecht · balance sheet €1.10m
- European Laboratory Supplies Manufacture of pharmaceutical preparations Soignies · balance sheet 257,481 €
- Exel Dental Manufacture of pharmaceutical preparations Braine-le-Comte · balance sheet 383,704 €
- Wandji Pharma International Manufacture of pharmaceutical preparations Tournai · balance sheet 357,118 €
Frequently asked questions about AdipoPharma Belgique
What is the revenue of AdipoPharma Belgique?
AdipoPharma Belgique files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AdipoPharma Belgique?
In Belgium, the VAT number is the company number prefixed with BE: BE1008146338 for AdipoPharma Belgique, if the company is VAT-registered. Its company number (CBE) is 1008.146.338.
Where is the registered office of AdipoPharma Belgique?
According to the CBE register, the registered office of AdipoPharma Belgique is in 6041 Charleroi.
What is the equity of AdipoPharma Belgique?
At the close of the 2025 financial year, the equity of AdipoPharma Belgique amounts to 1,766 €, a solvency of 0.4% of total assets.
Who manages AdipoPharma Belgique?
The register lists 1 active mandates at AdipoPharma Belgique. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AdipoPharma Belgique
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →